C4 Therapeutics, Inc. (CCCC)
About C4 Therapeutics, Inc.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $35.9M
- Net income
- -$105.0M
- Total assets
- $359.1M
- Market cap
- $375.9M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $375.9M
- Shares outstanding
- 122.9M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Oct 2, 2020
C4 Therapeutics, Inc. (CCCC) Stock Price
- Reported a net loss of $105.0M in FY2025.
- Trading 34% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review C4 Therapeutics, Inc..
Write a review
News about C4 Therapeutics, Inc.
News & sentiment via Polygon.io
C4 Therapeutics, Inc.: frequently asked questions
Is C4 Therapeutics, Inc. an American company?
C4 Therapeutics, Inc. is a US-based company headquartered in Watertown, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is C4 Therapeutics, Inc. headquartered?
C4 Therapeutics, Inc. is headquartered in Watertown, Massachusetts, United States.
Is C4 Therapeutics, Inc. publicly traded?
Yes — C4 Therapeutics, Inc. is a publicly traded company. Its stock trades under the ticker symbol CCCC on the NASDAQ.
What does C4 Therapeutics, Inc. do?
C4 Therapeutics, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
